Skip to main content
. 2021 Sep 14:1–15. doi: 10.1080/07391102.2021.1977698

Figure 4.

Figure 4.

Binding modes of shortlisted BSAAs against spike, RdRp, Mpro and helicase. (A) surface representation of structural domains of spike protein with Suramin and Imatinib shown in yellow (B and C) represent 2 D interactions of Suramin and Imatinib with spike, drug molecule is shown in grey ball and stick with interacting residues shown in disc green dotted lines represents hydrogen bonding(D) Surface representation of RdRp structural domains represented in their respective colors (E and F) 2 D representation of molecular interactions of Glycyrrhizin and Imatinib with RdRp catalytic cavity. Green dotted lines represent hydrogen bond while yellow and pink dotted lines represent pi-anion and pi-Sulphur interactions. (G) Surface representation of Mpro domains and features with bound drugs (Verdinexor and Imatinib) in yellow color (H and I) representation of molecular interaction in 2 D form. (J) Surface representation of helicase with domain features in respective colors (K and L) 2 D representation of molecular interaction of Suramin and Glycyrrhizin with ATP binding domain of helicase enzyme.